In short
- Twenty-seven adults with treatment-resistant OCD were studied after psilocybin sessions in a Yale clinical trial.
- Stronger mystical experiences were linked with lower OCD symptoms one week and 12 weeks later.
- Challenging or distressing experiences did not predict improvement, for better or for worse.
What the researchers did
This was a secondary analysis of a randomised, placebo-controlled trial. Participants had OCD that had not responded to at least two treatments. After their sessions they completed the MEQ-30 and a questionnaire about challenging experiences, and their symptoms were tracked over the following weeks.
What they found
Higher MEQ-30 scores went with lower OCD severity at one week and at 12 weeks, even after accounting for how severe symptoms were at the start and which treatment group people were in. The mystical subscale, which covers unity, sacredness and a sense of deep insight, showed the strongest links. How difficult the experience had been did not predict the outcome.
Why it matters
Many people worry that a hard experience will undo the benefit. This study suggests that difficulty itself is not the problem, and that what matters is whether there is also a sense of unity, sacredness or deep insight. It matches what we see: hard moments, well held, often become part of a meaningful whole. It is also why we measure mystical experience in our retreats with the MEQ-30.
Keep in mind
The sample was small and the analysis exploratory, so the findings need confirming in larger trials.
Experience it for yourself
Our small-group retreats combine careful preparation, ceremonies and integration, led by psychologists and psychotherapists.
See our retreatsThis summary is for information only and is not medical advice. Psychedelics are controlled substances in many countries, including the UK.
You may also like
Can Esketamine Bring On Mystical Experiences?
In routine depression care, 58% of patients treated with esketamine nasal spray had a mystical-type experience, and these seemed to matter for recovery.
Dr Christoph Zwolan · 17 April 2026
ResearchWhen Nothing Feels Good: Can Psilocybin Help Bring Back Joy?
A small trial tested psilocybin with psychological support for anhedonia, the loss of pleasure, in treatment-resistant depression. The results were mixed but hopeful.
Monika Knitter · 6 November 2026
ResearchFeeling Connected: The Key to Lasting Benefits After a Retreat?
Following 173 guests of guided psilocybin retreats in the Netherlands for a year, researchers found lasting wellbeing gains, linked above all to connectedness.
Danielle Tanner · 30 October 2026
